INTERNATIONAL PATENT: AB-RAYBIO THERAPEUTICS CO., LTD., 杭州景嘉航生物医药科技有限公司 FILES APPLICATION FOR "COMPOUND TARGETING AND BINDING TO FIBROBLAST ACTIVATION PROTEIN AND USE THEREOF"

Posted On: 2026-01-12

GENEVA, Jan. 12 -- AB-RAYBIO THERAPEUTICS CO., LTD. (Room 208095, 20th Floor, Yandafang Wenyuan Building, No. 426 Binwen Road, Puyan Street, Binjiang DistrictHangzhou, Zhejiang 310000), 杭州景嘉航生物医药科技有限公司 (中国浙江省杭州市滨江区浦沿街道滨文路426号岩大房文苑大厦20楼208095室) filed a patent application (PCT/CN2025/106513) for "COMPOUND TARGETING AND BINDING TO FIBROBLAST ACTIVATION PROTEIN AND USE THEREOF" on Jul 01, 2025. With publication no. WO/2026/007968, the details relate...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

INTERNATIONAL PATENT: AB-RAYBIO THERAPEUTICS CO., LTD., 杭州景嘉航生物医药科技有限公司 FILES APPLICATION FOR "COMPOUND TARGETING AND BINDING TO FIBROBLAST ACTIVATION PROTEIN AND USE THEREOF"